日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis.

以 Msx2 为靶点,抑制破骨细胞的融合命运,并在骨质疏松症的临床前模型中发挥合成代谢治疗作用

Ma Qingliang, Wang Shiyu, Xue Hong, Ni Linhui, Yuan Putao, Shen Yang, Zheng Bingjie, Wang Qingqing, Zhang Jiateng, Wang Haoming, Xie Hongwei, Jiang Chao, Qin An, Fan Shunwu, Xie Ziang, Jie Zhiwei

Visomitin Attenuates Pathological Bone Loss by Reprogramming Osteoclast Metabolism via the STAT3/LDHB Axis.

维索美汀通过 STAT3/LDHB 轴重编程破骨细胞代谢来减轻病理性骨丢失

Yuan Putao, Feng Zhenhua, Yang Haotian, Xue Hong, Xie Hongwei, Dai Zihan, Wang Haoming, Liu Ying, Pan Bin, Song Hongpu, Ye Huali, Xie Ziang, Shi Peihua, Sun Xuewu

Publisher Correction: Restrained Mitf-associated autophagy by Mulberroside A ameliorates osteoclastogenesis and counteracts OVX-Induced osteoporosis in mice

出版商更正:桑苷A抑制Mitf相关自噬可改善破骨细胞生成并对抗小鼠卵巢切除术诱导的骨质疏松症

Xue, Hong; Feng, Zhenhua; Yuan, Putao; Qiao, Li; Lou, Qiliang; Zhao, Xiangde; Ma, Qingliang; Wang, Shiyu; Shen, Yang; Ye, Huali; Cheng, Jiao; Wang, Jiying; Wan, Shuanglin; Zhang, Boya; Shi, Peihua; Sun, Xuewu

miR-21-5p targets SKP2 to reduce osteoclastogenesis in a mouse model of osteoporosis

miR-21-5p靶向SKP2,从而在骨质疏松症小鼠模型中减少破骨细胞生成

Huang, Yizhen; Yang, Yute; Wang, Jianle; Yao, Shasha; Yao, Teng; Xu, Yining; Chen, Zizheng; Yuan, Putao; Gao, Jun; Shen, Shuying; Ma, Jianjun

ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2/STAT3 and WNT/β-catenin signalling pathways

ML264通过抑制JAK2/STAT3和WNT/β-catenin信号通路来抑制骨肉瘤的生长和转移。

Huang, Hai; Han, Ying; Chen, Zhijun; Pan, Xin; Yuan, Putao; Zhao, Xiangde; Zhu, Hongfang; Wang, Jiying; Sun, Xuewu; Shi, Peihua